CHINA BIOLOGIC PRODS HLDGS I's ticker is CBPO and the CUSIP is G21515104. A total of 68 filers reported holding CHINA BIOLOGIC PRODS HLDGS I in Q4 2018. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $18,000 | -92.7% | 154 | -93.0% | 0.00% | – |
| Q3 2020 | $245,000 | +226.7% | 2,210 | +215.7% | 0.00% | – |
| Q1 2020 | $75,000 | -60.1% | 700 | -71.8% | 0.00% | -100.0% |
| Q4 2018 | $188,000 | -73.9% | 2,480 | -72.5% | 0.00% | -50.0% |
| Q3 2018 | $720,000 | +40.1% | 9,008 | +74.0% | 0.00% | 0.0% |
| Q2 2018 | $514,000 | – | 5,177 | +258750.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 2 | -99.9% | 0.00% | -100.0% |
| Q3 2017 | $164,000 | – | 1,781 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maso Capital Partners Ltd | 164,500 | $15,011,000 | 10.32% |
| HHLR ADVISORS, LTD. | 2,751,200 | $251,047,000 | 6.99% |
| Dalton Investments, Inc. | 113,851 | $10,389,000 | 4.54% |
| Point72 Hong Kong Ltd | 115,939 | $10,579,000 | 4.17% |
| York Capital Management Global Advisors, LLC | 991,233 | $90,450,000 | 4.05% |
| RUDMAN ERROL M | 58,000 | $5,293,000 | 3.57% |
| Greenwoods Asset Management Ltd | 479,580 | $43,762,000 | 2.69% |
| Parametrica Management Ltd | 3,663 | $334,000 | 0.71% |
| Temasek Holdings (Private) Ltd | 990,000 | $90,338,000 | 0.62% |
| Athos Capital Ltd | 8,290 | $756,000 | 0.49% |